Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma.
Shaoming SongMingzhen BaiXiaofei LiShiyi GongWenwen YangCaining LeiHongwei TianMoubo SiXiangyong HaoTiankang GuoPublished in: Expert review of molecular diagnostics (2022)
Alpha-fetoprotein (AFP); American Association for the Study of Liver Diseases (AASLD); Angiopoietin (Ang); Barcelona Clinic Liver Cancer stage (BCLC); Circulating endothelial progenitor (CEP); Circulating free DNA (cfDNA); Complete response (CR); Des-γ-carboxy prothrombin (DCP); Endothelium-derived nitric oxide synthase (eNOS); Hepatocellular carcinoma (HCC); Hepatocyte growth factor (HGF); Hepatoma arterial-embolization prognosis score (HAP); High mobility group box 1 (HMgb1); Interferon-gamma (IFN-γ); Long non-coding RNA (lncRNAs); Micro RNAs (miRNAs); Monocyte-to-lymphocyte ratio (MLR); National Comprehensive Cancer Network (NCCN); Neutrophil-lymphocyte ratio (NLR); Newcastle-Ottawa Scale (NOS); Nitric oxide (NO); Overall survival (OS); Partial response (PR); Platelet-lymphocyte ratio (PLR); Prediction of survival in advanced sorafenib-treated HCC (PROSASH); Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA); Prognostic nutritional index (PNI); Progression-free survival (PFS); Progressive disease (PD); Randomized controlled trials (RCTs); Response Evaluation Criteria in Solid Tumors (RECIST); Single nucleotide polymorphisms (SNPs); Sorafenib advanced HCC prognosis score (SAP); Stable disease (SD); Time to progression (TTP); Transcatheter arterial chemoembolization (TACE); Vascular endothelial growth factor (VEGF).
Keyphrases
- nitric oxide synthase
- nitric oxide
- free survival
- vascular endothelial growth factor
- long non coding rna
- growth factor
- endothelial cells
- peripheral blood
- dendritic cells
- poor prognosis
- hydrogen peroxide
- randomized controlled trial
- multiple sclerosis
- primary care
- systematic review
- transcription factor
- emergency department
- angiotensin ii
- meta analyses
- genome wide
- gene expression
- radiofrequency ablation
- double blind
- circulating tumor cells
- childhood cancer